These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22155205)

  • 1. Polyvalent mechanical bacterial lysate for the prevention of recurrent respiratory infections: a meta-analysis.
    Cazzola M; Anapurapu S; Page CP
    Pulm Pharmacol Ther; 2012 Feb; 25(1):62-8. PubMed ID: 22155205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open comparative, randomized controlled clinical study of a new immunostimulating bacterial lysate in the prophylaxis of upper respiratory tract infections.
    Macchi A; Vecchia LD
    Arzneimittelforschung; 2005; 55(5):276-81. PubMed ID: 15960427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of recurrent upper respiratory tract infections in a community of cloistered nuns using a new immunostimulating bacterial lysate. A randomized, double-blind clinical trial.
    Tricarico D; Varricchio A; D'Ambrosio S; Ascione E; Motta G
    Arzneimittelforschung; 2004; 54(1):57-63. PubMed ID: 14979610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: results of a prospective, placebo-controlled, randomized, double-blind study.
    Rutishauser M; Pitzke P; Grevers G; van Aubel A; Elsasser U; Kämmereit A
    Adv Ther; 1998; 15(6):330-41. PubMed ID: 10351117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sub-lingual administration of a polyvalent mechanical bacterial lysate (PMBL) in patients with moderate, severe, or very severe chronic obstructive pulmonary disease (COPD) according to the GOLD spirometric classification: A multicentre, double-blind, randomised, controlled, phase IV study (AIACE study: Advanced Immunological Approach in COPD Exacerbation).
    Braido F; Melioli G; Cazzola M; Fabbri L; Blasi F; Moretta L; Canonica GW;
    Pulm Pharmacol Ther; 2015 Aug; 33():75-80. PubMed ID: 25951945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The administration of a polyvalent mechanical bacterial lysate in elderly patients with COPD results in serological signs of an efficient immune response associated with a reduced number of acute episodes.
    Ricci R; Palmero C; Bazurro G; Riccio AM; Garelli V; Di Marco E; Cirillo C; Braido F; Canonica GW; Melioli G
    Pulm Pharmacol Ther; 2014 Feb; 27(1):109-13. PubMed ID: 23792312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between mucosal immunoresponse and clinical outcome in patients with recurrent upper respiratory tract infections treated with a mechanical bacterial lysate.
    Braido F; Schenone G; Pallestrini E; Reggiardo G; Cangemi G; Canonica GW; Melioli G
    J Biol Regul Homeost Agents; 2011; 25(3):477-85. PubMed ID: 22023774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Lantigen B in the prevention of bacterial respiratory infections.
    Pozzi E; Serra C
    Monaldi Arch Chest Dis; 2004; 61(1):19-27. PubMed ID: 15366332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self treatment with one of three self selected, ultramolecular homeopathic medicines for the prevention of upper respiratory tract infections in children. A double-blind randomized placebo controlled trial.
    Steinsbekk A; Bentzen N; Fønnebø V; Lewith G
    Br J Clin Pharmacol; 2005 Apr; 59(4):447-55. PubMed ID: 15801940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial.
    Jara-Pérez JV; Berber A
    Clin Ther; 2000 Jun; 22(6):748-59. PubMed ID: 10929921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects.
    Banche G; Allizond V; Mandras N; Garzaro M; Cavallo GP; Baldi C; Scutera S; Musso T; Roana J; Tullio V; Carlone NA; Cuffini AM
    Int J Immunopathol Pharmacol; 2007; 20(1):129-38. PubMed ID: 17346436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compilation and meta-analysis of randomized placebo-controlled clinical trials on the prevention of respiratory tract infections in children using immunostimulants.
    Berber A; Del-Rio-Navarro B
    J Investig Allergol Clin Immunol; 2001; 11(4):235-46. PubMed ID: 11908811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral purified bacterial extracts in chronic bronchitis and COPD: systematic review.
    Steurer-Stey C; Bachmann LM; Steurer J; Tramèr MR
    Chest; 2004 Nov; 126(5):1645-55. PubMed ID: 15539739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for optimizing compliance of paediatric patients for seasonal antibacterial vaccination with sublingually administered Polyvalent Mechanical Bacterial Lysates (PMBL).
    Rosaschino F; Cattaneo L
    Acta Biomed; 2004 Dec; 75(3):171-8. PubMed ID: 15796091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of recurrent infection of the upper and lower airways. Multicenter, open study over three months].
    Debelic M; Eckenberger HP
    Fortschr Med; 1992 Nov; 110(30):565-70. PubMed ID: 1468743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease.
    Donath E; Chaudhry A; Hernandez-Aya LF; Lit L
    Respir Med; 2013 Sep; 107(9):1385-92. PubMed ID: 23768735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, prospective study of an oral polyvalent bacterial lysate (Luivac) in the treatment of recurrent respiratory tract infections in Thai patients.
    Jareoncharsri P; Bunnag C; Tunsuriyawong P; Assanasane P; Voraprayoon S; Pinkaew B
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):223-30. PubMed ID: 15198340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.
    Grimfeld A; Holgate ST; Canonica GW; Bonini S; Borres MP; Adam D; Canseco Gonzalez C; Lobaton P; Patel P; Szczeklik A; Danzig MR; Roman I; Bismut H; Czarlewski W
    Clin Exp Allergy; 2004 Nov; 34(11):1665-72. PubMed ID: 15544588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical bacterial lysate administration prevents exacerbation in allergic asthmatic children-The EOLIA study.
    Emeryk A; Bartkowiak-Emeryk M; Raus Z; Braido F; Ferlazzo G; Melioli G
    Pediatr Allergy Immunol; 2018 Jun; 29(4):394-401. PubMed ID: 29575037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.